ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Fitzgerald Kevin Joseph โ CSO & EVP, Head of Research
Shares
280
Price
$372.93
Total Value
$104,420.40
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Fitzgerald Kevin Joseph |
|---|---|
| Title | CSO & EVP, Head of Research |
| Transaction Date | Jan 13, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jan 14, 2026 |
| Document Date | Jan 11, 2026 |
| Shares Sold | 280 |
| Price per Share | $372.93 |
| Total Value | $104,420.40 |
| Shares Owned After | 21,386 |
| Derivative | No |
| Accession Number | 0001735276-26-000011 |
| Document | View SEC Filing |